Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue-Jane Wang

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Journal of Biopharmaceutical Statistics|November 9, 2010
Editorial: Adaptive designs: appealing in development of therapeutics, and where do controversies lie?Sue-Jane Wang
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 9, 2009
Utility of adaptive strategy and adaptive design for biomarker-facilitated patient selection in pharmacogenomic or pharmacogenetic clinical development programSue-Jane Wang
Pharmaceutical Statistics|October 25, 2007
Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSISue-Jane Wang
Pharmaceutical Statistics|September 8, 2010
Multi-regional clinical trials--what are the challenges?Sue-Jane Wang
Contemporary Clinical Trials|August 10, 2020
Recent advances in clinical trial design considerations in Thera"nostics"Sue-Jane Wang
Journal of Biopharmaceutical Statistics|November 21, 2007
Discussion of the "White Paper of the PhRMA Working Group on adaptive dose-ranging designs"Sue-Jane Wang
Journal of Biopharmaceutical Statistics|November 9, 2010
Perspectives on the use of adaptive designs in clinical trials. Part I. Statistical considerations and issuesSue-Jane Wang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Modified toxicity probability interval design: a safer and more reliable method than the 3 + 3 design for practical phase I trialsYuan Ji, Sue-Jane Wang
Journal of Biopharmaceutical Statistics|January 8, 2014
Standardization for subgroup analysis in randomized controlled trialsRavi Varadhan, Sue-Jane Wang
Contemporary Clinical Trials|January 2, 2021
Guest editors-in-chief note to COVID-19 special issueZheng Su, Sue-Jane Wang
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Journal of Biopharmaceutical Statistics|November 9, 2010
Editorial: Adaptive designs: appealing in development of therapeutics, and where do controversies lie?Sue-Jane Wang
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 9, 2009
Utility of adaptive strategy and adaptive design for biomarker-facilitated patient selection in pharmacogenomic or pharmacogenetic clinical development programSue-Jane Wang
Pharmaceutical Statistics|October 25, 2007
Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSISue-Jane Wang
Pharmaceutical Statistics|September 8, 2010
Multi-regional clinical trials--what are the challenges?Sue-Jane Wang
Contemporary Clinical Trials|August 10, 2020
Recent advances in clinical trial design considerations in Thera"nostics"Sue-Jane Wang
Journal of Biopharmaceutical Statistics|November 21, 2007
Discussion of the "White Paper of the PhRMA Working Group on adaptive dose-ranging designs"Sue-Jane Wang
Journal of Biopharmaceutical Statistics|November 9, 2010
Perspectives on the use of adaptive designs in clinical trials. Part I. Statistical considerations and issuesSue-Jane Wang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Modified toxicity probability interval design: a safer and more reliable method than the 3 + 3 design for practical phase I trialsYuan Ji, Sue-Jane Wang
Journal of Biopharmaceutical Statistics|January 8, 2014
Standardization for subgroup analysis in randomized controlled trialsRavi Varadhan, Sue-Jane Wang
Contemporary Clinical Trials|January 2, 2021
Guest editors-in-chief note to COVID-19 special issueZheng Su, Sue-Jane Wang
Pageof 10